Werewolf Therapeutics (HOWL) Competitors $1.39 +0.06 (+4.51%) Closing price 04:00 PM EasternExtended Trading$1.36 -0.02 (-1.80%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOWL vs. FENC, TLSA, AVTE, PRQR, TRDA, SGMT, ENGN, GNFT, CRGX, and ACIUShould you be buying Werewolf Therapeutics stock or one of its competitors? The main competitors of Werewolf Therapeutics include Adherex Technologies (FENC), Tiziana Life Sciences (TLSA), Aerovate Therapeutics (AVTE), ProQR Therapeutics (PRQR), Entrada Therapeutics (TRDA), Sagimet Biosciences (SGMT), enGene (ENGN), GENFIT (GNFT), CARGO Therapeutics (CRGX), and AC Immune (ACIU). These companies are all part of the "pharmaceutical products" industry. Werewolf Therapeutics vs. Its Competitors Adherex Technologies Tiziana Life Sciences Aerovate Therapeutics ProQR Therapeutics Entrada Therapeutics Sagimet Biosciences enGene GENFIT CARGO Therapeutics AC Immune Adherex Technologies (NASDAQ:FENC) and Werewolf Therapeutics (NASDAQ:HOWL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings. Do analysts prefer FENC or HOWL? Adherex Technologies presently has a consensus target price of $13.33, indicating a potential upside of 50.32%. Werewolf Therapeutics has a consensus target price of $8.00, indicating a potential upside of 475.54%. Given Werewolf Therapeutics' higher possible upside, analysts clearly believe Werewolf Therapeutics is more favorable than Adherex Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adherex Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Werewolf Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in FENC or HOWL? 55.5% of Adherex Technologies shares are held by institutional investors. Comparatively, 64.8% of Werewolf Therapeutics shares are held by institutional investors. 11.8% of Adherex Technologies shares are held by company insiders. Comparatively, 23.6% of Werewolf Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer FENC or HOWL? In the previous week, Adherex Technologies had 7 more articles in the media than Werewolf Therapeutics. MarketBeat recorded 13 mentions for Adherex Technologies and 6 mentions for Werewolf Therapeutics. Werewolf Therapeutics' average media sentiment score of 0.01 beat Adherex Technologies' score of -0.01 indicating that Werewolf Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adherex Technologies 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Werewolf Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, FENC or HOWL? Adherex Technologies has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Werewolf Therapeutics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Which has preferable valuation and earnings, FENC or HOWL? Adherex Technologies has higher revenue and earnings than Werewolf Therapeutics. Adherex Technologies is trading at a lower price-to-earnings ratio than Werewolf Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdherex Technologies$33.30M7.41-$440K-$0.42-21.12Werewolf Therapeutics$1.88M33.81-$70.51M-$1.64-0.85 Is FENC or HOWL more profitable? Werewolf Therapeutics has a net margin of 0.00% compared to Adherex Technologies' net margin of -35.05%. Adherex Technologies' return on equity of 0.00% beat Werewolf Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Adherex Technologies-35.05% N/A -23.92% Werewolf Therapeutics N/A -111.87%-62.68% SummaryWerewolf Therapeutics beats Adherex Technologies on 9 of the 16 factors compared between the two stocks. Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOWL vs. The Competition Export to ExcelMetricWerewolf TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$63.57M$3.06B$5.76B$9.84BDividend YieldN/A2.26%3.95%4.02%P/E Ratio-0.8521.2231.3126.60Price / Sales33.81390.30461.30121.37Price / CashN/A44.4437.7659.36Price / Book1.538.0710.026.67Net Income-$70.51M-$54.08M$3.27B$265.59M7 Day Performance8.59%2.26%3.17%3.42%1 Month Performance2.96%3.42%4.34%1.09%1 Year Performance-39.04%18.61%44.11%23.85% Werewolf Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOWLWerewolf Therapeutics3.1659 of 5 stars$1.39+4.5%$8.00+475.5%-41.7%$63.57M$1.88M-0.8540News CoverageAnalyst ForecastFENCAdherex Technologies1.9265 of 5 stars$8.65-0.1%$13.33+54.1%+59.4%$240.87M$47.54M-20.5910Analyst RevisionTLSATiziana Life Sciences0.6967 of 5 stars$1.96-4.9%N/A+49.2%$240.71MN/A0.008AVTEAerovate TherapeuticsN/A$8.23+11.5%N/A-87.8%$238.55MN/A-2.7520High Trading VolumePRQRProQR Therapeutics3.031 of 5 stars$2.25-0.4%$8.00+255.6%+10.5%$237.78M$16.49M-4.89180News CoveragePositive NewsAnalyst RevisionGap UpTRDAEntrada Therapeutics3.1425 of 5 stars$5.63-8.3%$25.67+355.9%-66.0%$233.55M$210.78M-3.16110Positive NewsSGMTSagimet Biosciences2.9823 of 5 stars$7.08-0.4%$25.67+262.5%+155.9%$231.23M$2M-3.878ENGNenGene3.1221 of 5 stars$4.30-0.5%$23.29+441.5%-33.5%$220.77MN/A-2.6131Gap DownGNFTGENFIT1.9617 of 5 stars$4.19-4.5%$9.00+115.1%+3.4%$219.08M$76.77M0.00120News CoverageGap DownCRGXCARGO Therapeutics2.051 of 5 stars$4.47flat$15.40+244.5%N/A$216.17MN/A-0.96116ACIUAC Immune2.0492 of 5 stars$2.07-3.7%$12.00+479.7%-32.4%$215.88M$31.02M-3.57140Positive News Related Companies and Tools Related Companies Adherex Technologies Alternatives Tiziana Life Sciences Alternatives Aerovate Therapeutics Alternatives ProQR Therapeutics Alternatives Entrada Therapeutics Alternatives Sagimet Biosciences Alternatives enGene Alternatives GENFIT Alternatives CARGO Therapeutics Alternatives AC Immune Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOWL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access